209 related articles for article (PubMed ID: 7791124)
21. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
[TBL] [Abstract][Full Text] [Related]
22. Trial-selective effects of U50,488H, a kappa-opioid receptor agonist, on consummatory successive negative contrast.
Wood MD; Norris JN; Daniel AM; Papini MR
Behav Brain Res; 2008 Nov; 193(1):28-36. PubMed ID: 18514923
[TBL] [Abstract][Full Text] [Related]
23. Role of the nitric oxide pathway in kappa-opioid-induced hypothermia in rats.
Benamar K; Geller EB; Adler MW
J Pharmacol Exp Ther; 2002 Oct; 303(1):375-8. PubMed ID: 12235273
[TBL] [Abstract][Full Text] [Related]
24. Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50,488 in a mouse monocyte-like cell line.
Parkhill AL; Bidlack JM
Int Immunopharmacol; 2006 Jun; 6(6):1013-9. PubMed ID: 16644488
[TBL] [Abstract][Full Text] [Related]
25. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat hearts.
Xia Q; Sheng JZ; Tai KK; Wong TM
J Pharmacol Exp Ther; 1994 Feb; 268(2):930-4. PubMed ID: 8114007
[TBL] [Abstract][Full Text] [Related]
26. The role of serotonin in the effects of opioids in squirrel monkeys responding under a titration procedure: I. Kappa opioids.
Powell KR; Dykstra LA
J Pharmacol Exp Ther; 1995 Sep; 274(3):1305-16. PubMed ID: 7562503
[TBL] [Abstract][Full Text] [Related]
27. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
Wilson JL; Nayanar V; Walker JS
Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
[TBL] [Abstract][Full Text] [Related]
28. Kappa-opioid regulation of thymocyte IL-7 receptor and C-C chemokine receptor 2 expression.
Zhang L; Rogers TJ
J Immunol; 2000 May; 164(10):5088-93. PubMed ID: 10799865
[TBL] [Abstract][Full Text] [Related]
29. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation.
Li JG; Luo LY; Krupnick JG; Benovic JL; Liu-Chen LY
J Biol Chem; 1999 Apr; 274(17):12087-94. PubMed ID: 10207034
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor.
Raynor K; Kong H; Hines J; Kong G; Benovic J; Yasuda K; Bell GI; Reisine T
J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192
[TBL] [Abstract][Full Text] [Related]
31. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.
Wang YJ; Rasakham K; Huang P; Chudnovskaya D; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2011 Nov; 339(2):438-50. PubMed ID: 21841040
[TBL] [Abstract][Full Text] [Related]
32. The kappa-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs.
Brent PJ; Chahl LA; Cantarell PA; Kavanagh C
Eur J Pharmacol; 1993 Sep; 241(2-3):149-56. PubMed ID: 7902288
[TBL] [Abstract][Full Text] [Related]
33. Peripheral kappa 1-opioid receptor-mediated analgesia in mice.
Kolesnikov Y; Jain S; Wilson R; Pasternak GW
Eur J Pharmacol; 1996 Aug; 310(2-3):141-3. PubMed ID: 8884210
[TBL] [Abstract][Full Text] [Related]
34. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice.
Kuzmin AV; Semenova S; Gerrits MA; Zvartau EE; Van Ree JM
Eur J Pharmacol; 1997 Mar; 321(3):265-71. PubMed ID: 9085036
[TBL] [Abstract][Full Text] [Related]
35. The kappa-opioid receptor agonist, U50,488H, exerts antidystonic activity in a mutant hamster model of generalized dystonia.
Richter A; Löscher W
Eur J Pharmacol; 1993 May; 236(2):289-94. PubMed ID: 8391460
[TBL] [Abstract][Full Text] [Related]
36. U50,488, a highly selective kappa opioid: anticonvulsant profile in rats.
Tortella FC; Robles L; Holaday JW
J Pharmacol Exp Ther; 1986 Apr; 237(1):49-53. PubMed ID: 3007743
[TBL] [Abstract][Full Text] [Related]
37. Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization.
Chen C; Chiu YT; Wu W; Huang P; Mann A; Schulz S; Liu-Chen LY
Biochem J; 2016 Feb; 473(4):497-508. PubMed ID: 26635353
[TBL] [Abstract][Full Text] [Related]
38. The Protective Effects of Κ-Opioid Receptor Stimulation in Hypoxic Pulmonary Hypertension Involve Inhibition of Autophagy Through the AMPK-MTOR Pathway.
Zhou Y; Wang Y; Wang X; Tian X; Zhang S; Yang F; Guo H; Fan R; Feng N; Jia M; Gu X; Wang Y; Li J; Pei J
Cell Physiol Biochem; 2017; 44(5):1965-1979. PubMed ID: 29224002
[TBL] [Abstract][Full Text] [Related]
39. [Inhibitory effects of kappa-opioid receptor stimulation on cultured myocardial cells].
Yang YL; Wang HX; Yang YH
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2002 Nov; 18(4):358-61. PubMed ID: 21174814
[TBL] [Abstract][Full Text] [Related]
40. Morphine suppresses primary humoral immune responses by a predominantly indirect mechanism.
Pruett SB; Han YC; Fuchs BA
J Pharmacol Exp Ther; 1992 Sep; 262(3):923-8. PubMed ID: 1527733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
